Table 6 |
||||
|
Multivariate logistic regression analysis of factors affecting tumor response rate (ZIO 50%) |
||||
|
Odds ratio |
(95% CI) |
P |
||
|
|
||||
|
After EC + DOC |
||||
|
Tumor stage |
||||
|
T2 |
1.000 |
|||
|
T3 |
2.246 |
(0.290-17.420) |
0.4388 |
|
|
Nodal status |
||||
|
N- |
1.000 |
|||
|
N+ |
3.651 |
(0.346-38.506) |
0.2813 |
|
|
Subtype |
||||
|
Luminal A, B |
1.000 |
|||
|
HER2, Basal-like |
2.484 |
(0.464-13.287) |
0.2874 |
|
|
DDR score |
||||
|
0, 1, 2 |
1.000 |
|||
|
3, 4 |
6.694 |
(1.088-41.182) |
0.0402 |
|
|
|
||||
|
CI, confidence interval; DDR, DNA Damage Response; DOC, docetaxel; EC, epirubicin plus cyclophosphamide; HER, human epidermal growth factor receptor. |
||||
|
Asakawa et al. Breast Cancer Research 2010 12:R17 doi:10.1186/bcr2486 |
||||
